PT943326E - Composicao em po para administracao nasal - Google Patents

Composicao em po para administracao nasal

Info

Publication number
PT943326E
PT943326E PT97905398T PT97905398T PT943326E PT 943326 E PT943326 E PT 943326E PT 97905398 T PT97905398 T PT 97905398T PT 97905398 T PT97905398 T PT 97905398T PT 943326 E PT943326 E PT 943326E
Authority
PT
Portugal
Prior art keywords
water
absorbing
base material
drug
gel
Prior art date
Application number
PT97905398T
Other languages
English (en)
Inventor
Takao Fujii
Yuji Makino
Masahiko Dohi
Yoshihisa Nishibe
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26378964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT943326(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of PT943326E publication Critical patent/PT943326E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97905398T 1996-02-27 1997-02-26 Composicao em po para administracao nasal PT943326E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3955396 1996-02-27
JP4107996 1996-02-28

Publications (1)

Publication Number Publication Date
PT943326E true PT943326E (pt) 2003-12-31

Family

ID=26378964

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97905398T PT943326E (pt) 1996-02-27 1997-02-26 Composicao em po para administracao nasal

Country Status (13)

Country Link
US (3) US6881423B2 (pt)
EP (1) EP0943326B2 (pt)
JP (1) JP3634380B2 (pt)
KR (1) KR100568436B1 (pt)
CN (1) CN1155368C (pt)
AT (1) ATE247456T1 (pt)
AU (1) AU722319B2 (pt)
CA (1) CA2247191C (pt)
DE (1) DE69724272T3 (pt)
DK (1) DK0943326T4 (pt)
ES (1) ES2205177T5 (pt)
PT (1) PT943326E (pt)
WO (1) WO1997031626A1 (pt)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2205177T5 (es) * 1996-02-27 2007-08-01 Teijin Limited Composicion en polvo para administracion nasal.
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AU762145C (en) * 1998-08-26 2005-03-17 Teijin Limited Powdery pernasal compositions
ATE310501T1 (de) * 1998-12-09 2005-12-15 Chiron Corp Verabreichung von neurotropischen wirkstoffen in das zentrale nervensystem
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
DE60137452D1 (de) * 2000-11-29 2009-03-05 Itoham Foods Inc Pulverzubereitungen und verfahren zu ihrer herstellung
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
RU2299743C2 (ru) * 2001-07-05 2007-05-27 Транслэйшнл Рисерч Лтд. Композиции инсулина для носового введения
US20050014681A1 (en) * 2001-11-26 2005-01-20 Yoshiharu Minamitake Medicinal compositions for nasal absorption
CA2479751C (en) 2002-03-20 2008-06-03 Trent Poole Inhalation apparatus
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
AU2003272517A1 (en) * 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
EP1607117A4 (en) 2003-03-27 2007-10-24 Bioactis Ltd APPLICATOR FOR POWDER MEDICATION IN THE NOSE CAVE
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US8673360B2 (en) * 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
BRPI0514263B8 (pt) 2004-08-20 2021-05-25 Mannkind Corp método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida
DK2314298T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Microparticles comprising diketopiperazinsalte for drug delivery
US7115561B2 (en) * 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
GB2420707A (en) * 2004-10-11 2006-06-07 Nasaleze Patents Ltd Compositions for intranasal administration
JP5254618B2 (ja) * 2004-10-11 2013-08-07 ナサリーズ・ピーピーエム・リミテッド 経鼻投与用組成物
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
US20070111964A1 (en) * 2005-08-17 2007-05-17 Fleming And Company, Pharmaceuticals Vitamin B12 nasal spray and method of use
JP5276982B2 (ja) 2005-08-26 2013-08-28 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ オキシトシンの投与による頭痛の処置のための方法
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
JP5415769B2 (ja) 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
AU2008316634B2 (en) * 2007-10-24 2014-02-27 Mannkind Corporation Method of preventing adverse effects by GLP-1
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
AU2009257311B2 (en) 2008-06-13 2014-12-04 Mannkind Corporation A dry powder inhaler and system for drug delivery
DK2300083T3 (da) 2008-06-20 2013-07-22 Mannkind Corp Interaktivt apparat og fremgangsmåde til realtids-profilering af inhalationsforsøg
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
ES2533987T3 (es) 2009-09-02 2015-04-16 Nippon Soda Co., Ltd. Partículas de hidroxipropil celulosa
EP2298286B8 (en) * 2009-09-18 2017-08-09 SiTec PharmaBio SL Process for dewatering of product powders
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
US8802622B2 (en) 2010-03-19 2014-08-12 Daiichi Sankyo Company, Limited Composition for nasal administration and method for preparing same
ES2625858T3 (es) 2011-04-01 2017-07-20 Mannkind Corporation Paquete de tipo blíster para cartuchos farmacéuticos
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
JP6018640B2 (ja) 2011-10-24 2016-11-02 マンカインド コーポレイション 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
JP5717658B2 (ja) * 2012-01-13 2015-05-13 シスメックス株式会社 副腎皮質刺激ホルモンの検出方法および吸着剤
US9789071B2 (en) 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
ES2624294T3 (es) 2012-07-12 2017-07-13 Mannkind Corporation Sistemas de suministro de fármacos en polvo seco
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
DK2964199T3 (da) * 2013-03-04 2020-06-15 Besins Healthcare Lu Sarl Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
EP2970149B1 (en) 2013-03-15 2019-08-21 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
CA2923270A1 (en) * 2013-09-03 2015-03-12 Shin Nippon Biomedical Laboratories Ltd. (Snbl) Intranasal formulation for the treatment of cardiopulmonary resuscitation (cpr), cardiac life support (cls), anaphylaxis and/or anaphylactoid reactions
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
PT3242676T (pt) 2015-01-07 2023-12-06 TONIX Pharmaceuticals Holding Corp Formulações de ocitocina que contém magnésio e métodos de uso
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
AU2018371435B2 (en) * 2017-11-27 2023-12-14 Aska Pharmaceutical Co., Ltd. Powder preparation for nasal administration
CN108158978A (zh) * 2018-03-26 2018-06-15 厦门传福堂药业有限公司 一种高分子水性凝胶及其制备方法和用途
EP3970696A4 (en) * 2019-05-16 2023-03-01 Shin Nippon Biomedical Laboratories, Ltd. POWDER PREPARATION FOR TRANSNASAL ADMINISTRATION AND MANUFACTURING METHOD THEREOF
US20240041089A1 (en) * 2020-12-16 2024-02-08 Liw Innovation Ab A new powder composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) † 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS607965B2 (ja) * 1980-08-07 1985-02-28 帝人株式会社 鼻腔粘膜投与用粉剤の製造法
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
EP0187433B1 (en) 1983-08-01 1990-12-27 Teijin Limited Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
JPS6032714A (ja) * 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
JPS6034925A (ja) 1983-08-04 1985-02-22 Mitsubishi Chem Ind Ltd ２−ヒドロキシイソフタルアルデヒド類の製造法
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
JPS6242888A (ja) 1985-08-21 1987-02-24 カシオ計算機株式会社 太陽電池を備えたｉｃカ−ド
GB2193891B (en) 1986-08-18 1990-07-25 Sandoz Ltd Nasal pharmaceutical composition containing a somatostatin anologue.
JP3068924B2 (ja) 1990-11-29 2000-07-24 旭硝子株式会社 熱線遮断膜
EP0571671B1 (en) 1992-05-26 1997-09-17 The Procter & Gamble Company A Pharmaceutical composition in powder form
EP0606486B1 (en) * 1992-06-12 2001-08-29 Teijin Limited Pharmaceutical preparation for intra-airway administration
JP2974412B2 (ja) 1993-07-30 1999-11-10 帝人株式会社 ペプチド，蛋白質性薬物経鼻粉剤
JPH07242550A (ja) 1994-03-02 1995-09-19 Teijin Ltd 二次性副甲状腺機能亢進症治療剤
ES2205177T5 (es) * 1996-02-27 2007-08-01 Teijin Limited Composicion en polvo para administracion nasal.

Also Published As

Publication number Publication date
KR19990087261A (ko) 1999-12-15
US7731990B2 (en) 2010-06-08
WO1997031626A1 (fr) 1997-09-04
CN1216464A (zh) 1999-05-12
EP0943326B1 (en) 2003-08-20
EP0943326A4 (en) 2000-12-20
KR100568436B1 (ko) 2007-04-25
ATE247456T1 (de) 2003-09-15
CA2247191C (en) 2005-01-04
US8206748B2 (en) 2012-06-26
EP0943326A1 (en) 1999-09-22
DE69724272T3 (de) 2007-05-10
DE69724272D1 (de) 2003-09-25
AU722319B2 (en) 2000-07-27
DE69724272T2 (de) 2004-06-09
US6881423B2 (en) 2005-04-19
EP0943326B2 (en) 2006-12-20
US20020012688A1 (en) 2002-01-31
US20040219108A1 (en) 2004-11-04
CA2247191A1 (en) 1997-09-04
DK0943326T4 (da) 2007-01-22
AU2230297A (en) 1997-09-16
ES2205177T3 (es) 2004-05-01
CN1155368C (zh) 2004-06-30
US20100047206A1 (en) 2010-02-25
DK0943326T3 (da) 2003-12-08
ES2205177T5 (es) 2007-08-01
JP3634380B2 (ja) 2005-03-30

Similar Documents

Publication Publication Date Title
PT943326E (pt) Composicao em po para administracao nasal
KR880700668A (ko) 특정 생체조직 부위로의 전달을 위한 아미노산 킬레이트의 조성물
KR890004686A (ko) 서방성 에토돌락
IT1200589B (it) Derivati naturali attivita farmagologica
ME00880B (me) Inkluzioni kompleks aril-heterocikličnih soli
DK0921812T3 (da) Insulinpræparater, som indeholder NaCi
ATE135229T1 (de) Antimikrobielle proteine, zusammensetzungen, welche dieselben enthalten, und deren anwendungen
BG104020A (en) Pharmaceutical composition for mucous membrane application
DK1007082T3 (da) Modificeret tumor nekrose faktor
YU20197A (sh) Analozi vitamina d3, farmaceutske kompozicije koje ih sadrže kao aktivnu materiju i njihova upotreba u proizvodnji farmaceutskih kompozicija
AU653371B2 (en) Pharmaceutical compositions
TR200100896T2 (tr) İkameli propanol türevleri, imalat yöntemleri, bileşimleri içeren ilaçlar, kullanımları
JPS5793915A (en) Thrombin inhibiting substance, manufacture and thrombin inhibiting drug composition containing same
ATE103178T1 (de) T-pa pro stabilisierung.
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
ATE94168T1 (de) Peptide.
ATE227287T1 (de) Derivate des benzopyrans und des benzothiopyrans, deren herstellung und deren verwendung als agonisten von dopamin rezeptoren
YU47871B (sh) Derivati aminokiselina